• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与靶向乳清苷单磷酸脱羧酶的核苷酸相关的结构多样性和可塑性。

Structural diversity and plasticity associated with nucleotides targeting orotidine monophosphate decarboxylase.

作者信息

Poduch Ewa, Wei Lianhu, Pai Emil F, Kotra Lakshmi P

机构信息

Center for Molecular Design and Preformulations, Toronto General Research Institute, Toronto General Hospital, Toronto, ON, Canada.

出版信息

J Med Chem. 2008 Feb 14;51(3):432-8. doi: 10.1021/jm700968x. Epub 2008 Jan 9.

DOI:10.1021/jm700968x
PMID:18181562
Abstract

Orotidine monophosphate decarboxylase (ODCase) generally accepts pyrimidine-based mononucleotides as ligands, but other nucleotides are also known to bind to this enzyme. We investigated the kinetic properties of eight common and endogenous nucleotides with ODCases from three species: Methanobacterium thermoautotrophicum, Plasmodium falciparum, and Homo sapiens. UMP and XMP exhibited higher affinities as compared to the other nucleotides tested. The product of ODCase catalyzed decarboxylation, UMP, displayed inhibition constants (K(i)) of 330 microM against the Mt enzyme and of 210 and 220 microM against the Pf and Hs ODCases, respectively. The K(i) values for XMP were 130 microM and 43 microM, respectively, for Mt and Pf ODCases. Interestingly, XMP's affinity for human ODCase (K(i) = 0.71 microM) is comparable and even slightly better than that of the substrate OMP. Binding of various nucleotides and their structural features in the context of ODCase inhibition and inhibitor design are discussed.

摘要

乳清苷单磷酸脱羧酶(ODCase)通常将基于嘧啶的单核苷酸作为配体,但已知其他核苷酸也能与这种酶结合。我们研究了八种常见的内源性核苷酸与来自三种物种(嗜热自养甲烷杆菌、恶性疟原虫和智人)的ODCase的动力学特性。与测试的其他核苷酸相比,UMP和XMP表现出更高的亲和力。ODCase催化脱羧反应的产物UMP对Mt酶的抑制常数(K(i))为330微摩尔,对Pf和Hs ODCase的抑制常数分别为210和220微摩尔。XMP对Mt和Pf ODCase的K(i)值分别为130微摩尔和43微摩尔。有趣的是,XMP对人ODCase的亲和力(K(i)=0.71微摩尔)与底物OMP相当,甚至略好。讨论了在ODCase抑制和抑制剂设计背景下各种核苷酸的结合及其结构特征。

相似文献

1
Structural diversity and plasticity associated with nucleotides targeting orotidine monophosphate decarboxylase.与靶向乳清苷单磷酸脱羧酶的核苷酸相关的结构多样性和可塑性。
J Med Chem. 2008 Feb 14;51(3):432-8. doi: 10.1021/jm700968x. Epub 2008 Jan 9.
2
Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.利用生物电子等排体替换设计乳清苷单磷酸脱羧酶抑制剂并测定抑制动力学
J Med Chem. 2006 Aug 10;49(16):4937-45. doi: 10.1021/jm060202r.
3
A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.一种具有抗疟活性的强力共价型乳清酸核苷5'-单磷酸脱羧酶抑制剂。
J Med Chem. 2007 Mar 8;50(5):915-21. doi: 10.1021/jm060827p. Epub 2007 Feb 10.
4
Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase.恶性疟原虫乳清苷5'-单磷酸脱羧酶催化乳清苷5'-单磷酸(OMP)脱羧反应的结构基础。
J Biochem. 2008 Jan;143(1):69-78. doi: 10.1093/jb/mvm193. Epub 2007 Nov 1.
5
Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum.恶性疟原虫乳清苷5'-单磷酸脱羧酶的结构与抑制作用
Biochemistry. 2008 Mar 25;47(12):3842-54. doi: 10.1021/bi702390k. Epub 2008 Feb 28.
6
Substrate binding induces domain movements in orotidine 5'-monophosphate decarboxylase.底物结合会诱导乳清苷5'-单磷酸脱羧酶中的结构域运动。
J Mol Biol. 2002 May 10;318(4):1019-29. doi: 10.1016/S0022-2836(02)00200-0.
7
Lys314 is a nucleophile in non-classical reactions of orotidine-5'-monophosphate decarboxylase.赖氨酸314是乳清苷-5'-单磷酸脱羧酶非经典反应中的亲核试剂。
Chemistry. 2009 Jul 6;15(27):6619-25. doi: 10.1002/chem.200900397.
8
A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.人类疟原虫恶性疟原虫中乳清酸磷酸核糖基转移酶和乳清苷5'-单磷酸脱羧酶的新型酶复合物:物理缔合、动力学及抑制特性
Biochemistry. 2005 Feb 8;44(5):1643-52. doi: 10.1021/bi048439h.
9
Quantum and classical simulations of orotidine monophosphate decarboxylase: support for a direct decarboxylation mechanism.鸟苷酸单磷酸脱羧酶的量子和经典模拟:对直接脱羧机制的支持。
Biochemistry. 2013 Jun 25;52(25):4382-90. doi: 10.1021/bi400190v. Epub 2013 Jun 11.
10
Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.具有不寻常扭曲结构的新型胞苷基或尿苷-5'-单磷酸脱羧酶抑制剂。
J Med Chem. 2012 Nov 26;55(22):9988-97. doi: 10.1021/jm301176r. Epub 2012 Oct 18.

引用本文的文献

1
Substrate distortion contributes to the catalysis of orotidine 5'-monophosphate decarboxylase.底物扭曲有助于乳清酸 5′-单磷酸脱羧酶的催化。
J Am Chem Soc. 2013 Nov 20;135(46):17432-43. doi: 10.1021/ja408197k. Epub 2013 Nov 11.
2
Atomic resolution structure of the orotidine 5'-monophosphate decarboxylase product complex combined with surface plasmon resonance analysis: implications for the catalytic mechanism.原子分辨率的乳清酸 5′-单磷酸脱羧酶产物复合物结构与表面等离子体共振分析结合:对催化机制的影响。
J Biol Chem. 2013 Mar 29;288(13):9011-6. doi: 10.1074/jbc.M112.427252. Epub 2013 Feb 10.
3
Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase.
靶向乳清酸 5'-单磷酸脱羧酶的氟化核苷酸衍生物的新相互作用。
J Med Chem. 2011 Apr 28;54(8):2891-901. doi: 10.1021/jm101642g. Epub 2011 Mar 21.
4
Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase.别嘌醇 5'-单磷酸脱羧酶抑制剂的结构决定因素。
Bioorg Med Chem. 2010 Jun 1;18(11):4032-41. doi: 10.1016/j.bmc.2010.04.017. Epub 2010 Apr 9.